6-Paradol Alleviates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Inhibiting AKT/mTOR Axis

Introduction: Benign prostatic hyperplasia (BPH) is a common disease among elderly men. Its pharmacological treatment is still unsatisfactory. 6-Paradol (6-PD) is an active metabolite found in many members of the <i>Zingiberaceae</i> family. It was reported to possess anti-proliferative, antioxidant...

Descrición completa

Detalles Bibliográficos

Principais autores:	Lenah S. Binmahfouz, Haifa Almukadi, Abdulmohsin J. Alamoudi, Ali M. El-Halawany, Hossam M. Abdallah, Mardi M. Algandaby, Gamal A. Mohamed, Sabrin R. M. Ibrahim, Faraj A. Alghamdi, Majed Al-Shaeri, Ashraf B. Abdel-Naim
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2022-10-01
Series:	Plants
Assuntos:	benign prostatic hyperplasia 6-Paradol AKT mTOR
Acceso en liña:	https://www.mdpi.com/2223-7747/11/19/2602
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!